Institutional Biosafety Committee Resources

In compliance with the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, Stanley Manne Children’s Research Institute has established an Institutional Biosafety Committee (IBC) which is responsible for the local review and oversight of all research utilizing recombinant and synthetic nucleic acid molecules.

Forms

Safety Protocol Form (Revised 10/25/2017)
Amendment Request Form (Revised 10/25/2017)
Personnel Addition Form (Revised 10/18/2017)
Inactivation Form​​​ (Revised 10/18/2017)
Biosafety Registration for Non-Clinical Submissions​ (Revised 10/18/2017)
Pre-Registration of Clinical Protocol (Revised 07/26/2017)
Biosafety Registration of Clinical Protocol (Revised 09/18/2017)
Laboratory Safety Protocol Sample​ PDF
IBC SOP on Handling and Preparation of Biological Agents PDF

Useful Information

Submission Deadlines and Meeting Dates 2018​​ PDF
Institutional Biosafety Program​ PDF
IBC Policy for Use of Human Cells and Tissues for Research PDF
Biosafety Considerations for Research with Lentiviral Vectors PDF
NIH Guidelines for Research Involving Recom​binant or Synthetic Nucleic Acid Molecules​ PDF
Investigator Responsibilities under the NIH Gu​idelines​ PDF
NIH Office of Science Policy Guidelines
Guidelines for the Use of Transgenic Animals PDF
Animal Research Covered under NIH Guidelines​​ PDF